Alterations in this pathway are found in up to 70% of breast cancers, leading to hyperactivation that promotes tumor initiation, proliferation, and resistance to apoptosis.3) In skeletal muscle, insulin binding to its receptor activates PI3K–AKT, promoting GLUT-4 translocation and glucose uptake. The gene discussed is SLC2A4; the disease is breast carcinoma.